Dr. Michael E. Roth, MD

Dr. Roth practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Roth's NPI, 1790915254, was assigned on July 19, 2009. Dr. Roth graduated from New York University School of Medicine in 2006. Dr. Roth holds Texas license R2724.

Dr. Roth's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Roth's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is UT Physicians. Dmand AI also links Dr. Roth to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Roth practices. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Roth's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Roth is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Roth's licenses on file in 11 states: Texas, Florida, Georgia, Washington, Arizona, Louisiana, Mississippi, Oklahoma, Tennessee, Alabama and New York.

Across all payers, Dmand AI patient panel data puts Dr. Roth's median patient age at 31, with 54% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Roth for performance year 2024, reported as part of a group. Dr. Roth accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 395 papers to Dr. Roth, published from 2007 to 2025. 2024 was the busiest year, with 39. The most frequent topics are Asthma, Cancer Survivors and Cells, Cultured. Dr. Roth has published most often in Pediatr Blood Cancer. Dr. Roth's most frequent co-authors are David R. Freyer, DO, Amy Berkman and Jonathan Benjamin Gill, MD.

Dmand AI links Dr. Roth to 2 clinical trials. Conditions studied include Hodgkin Disease and Sarcoma.

CMS Open Payments shows 2 general payments to Dr. Roth from 2 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Philips Electronics North America Corporation paid the most, $11. It also lists 11 research payments totaling $23,870 from 2023 to 2025.

Dmand AI lists 12 awards for Dr. Roth, most recently Henry L. Moses Award in Basic Science in 2014.

Dr. Roth graduated from New York University School of Medicine in 2006.

Dr. Roth is in network with 16 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.